Anna-katharina Meinecke
Berlin, BE 13342, Germany
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 20 publications
Linking clinical trial data with real-world data for enhanced clinical evidence generation: methodological considerations and recommendations.
Journal: Frontiers in pharmacology
Published: May 21, 2026
Validation of the GetReal Trial Tool - Facilitating discussion and understanding more pragmatic design choices and their implications.
Journal: Contemporary clinical trials
Published: July 05, 2022
The GetReal Trial Tool: design, assess and discuss clinical drug trials in light of Real World Evidence generation.
Journal: Journal of clinical epidemiology
Published: August 27, 2021
Patient Preferences for Nonvitamin K Antagonist Oral Anticoagulants in Stroke Prevention: A Multicountry Discrete Choice Experiment.
Journal: Cardiology research and practice
Published: September 06, 2019
Rivaroxaban's Impact on Renal Decline in Patients With Nonvalvular Atrial Fibrillation: A US MarketScan Claims Database Analysis.
Journal: Clinical and applied thrombosis/hemostasis : official journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis
Published: August 09, 2019
Rivaroxaban vs. warfarin and renal outcomes in non-valvular atrial fibrillation patients with diabetes.
Journal: European heart journal. Quality of care & clinical outcomes
Published: July 11, 2019
Effectiveness and safety of rivaroxaban vs. warfarin in patients with non-valvular atrial fibrillation and coronary or peripheral artery disease.
Journal: European heart journal. Cardiovascular pharmacotherapy
Published: July 01, 2019
Effectiveness and safety of rivaroxaban and warfarin for prevention of major adverse cardiovascular or limb events in patients with non-valvular atrial fibrillation and type 2 diabetes.
Journal: Diabetes, obesity & metabolism
Published: April 10, 2019
Rivaroxaban Versus Warfarin in Patients With Nonvalvular Atrial Fibrillation and Severe Kidney Disease or Undergoing Hemodialysis.
Journal: The American journal of medicine
Published: March 31, 2019
Influence of Polypharmacy on the Effectiveness and Safety of Rivaroxaban Versus Warfarin in Patients With Nonvalvular Atrial Fibrillation.
Journal: Pharmacotherapy
Published: January 01, 2019
Estimation of the costs attributable to vitamin K antagonist treatment in patients with non-valvular atrial fibrillation from a French societal perspective.
Journal: Journal of market access & health policy
Published: September 12, 2018
Last Updated: 09/26/2026